AU2015382370A1 - Coherent single layer high strength synthetic polymer composites for prosthetic valves - Google Patents
Coherent single layer high strength synthetic polymer composites for prosthetic valves Download PDFInfo
- Publication number
- AU2015382370A1 AU2015382370A1 AU2015382370A AU2015382370A AU2015382370A1 AU 2015382370 A1 AU2015382370 A1 AU 2015382370A1 AU 2015382370 A AU2015382370 A AU 2015382370A AU 2015382370 A AU2015382370 A AU 2015382370A AU 2015382370 A1 AU2015382370 A1 AU 2015382370A1
- Authority
- AU
- Australia
- Prior art keywords
- prosthetic valve
- leaflet
- less
- fibers
- single layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002356 single layer Substances 0.000 title claims abstract description 280
- 230000001427 coherent effect Effects 0.000 title claims abstract description 253
- 229920001059 synthetic polymer Polymers 0.000 title claims description 56
- 239000002131 composite material Substances 0.000 title abstract description 125
- 239000011148 porous material Substances 0.000 claims abstract description 337
- 239000000463 material Substances 0.000 claims abstract description 189
- 229920001971 elastomer Polymers 0.000 claims abstract description 159
- 239000000806 elastomer Substances 0.000 claims abstract description 159
- 210000003709 heart valve Anatomy 0.000 claims abstract description 50
- 239000000835 fiber Substances 0.000 claims description 393
- 239000012528 membrane Substances 0.000 claims description 237
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 claims description 125
- 238000012360 testing method Methods 0.000 claims description 120
- -1 polyethylene Polymers 0.000 claims description 77
- 238000000034 method Methods 0.000 claims description 76
- 239000004698 Polyethylene Substances 0.000 claims description 75
- 229920000573 polyethylene Polymers 0.000 claims description 75
- 238000005452 bending Methods 0.000 claims description 67
- 229920001296 polysiloxane Polymers 0.000 claims description 66
- 230000006835 compression Effects 0.000 claims description 62
- 238000007906 compression Methods 0.000 claims description 62
- 229920002313 fluoropolymer Polymers 0.000 claims description 59
- 239000004811 fluoropolymer Substances 0.000 claims description 59
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 51
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 51
- 230000005540 biological transmission Effects 0.000 claims description 44
- 239000007788 liquid Substances 0.000 claims description 41
- 229920001973 fluoroelastomer Polymers 0.000 claims description 26
- 229920000642 polymer Polymers 0.000 claims description 26
- 229920001577 copolymer Polymers 0.000 claims description 19
- 229920005597 polymer membrane Polymers 0.000 claims description 10
- 230000008878 coupling Effects 0.000 claims description 9
- 238000010168 coupling process Methods 0.000 claims description 9
- 238000005859 coupling reaction Methods 0.000 claims description 9
- BLTXWCKMNMYXEA-UHFFFAOYSA-N 1,1,2-trifluoro-2-(trifluoromethoxy)ethene Chemical compound FC(F)=C(F)OC(F)(F)F BLTXWCKMNMYXEA-UHFFFAOYSA-N 0.000 claims description 8
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 241000269980 Pleuronectidae Species 0.000 claims 54
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims 3
- 239000007943 implant Substances 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 120
- 239000000523 sample Substances 0.000 description 31
- 239000010408 film Substances 0.000 description 29
- 239000011159 matrix material Substances 0.000 description 28
- 229920001721 polyimide Polymers 0.000 description 25
- 230000008569 process Effects 0.000 description 22
- 239000004642 Polyimide Substances 0.000 description 20
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 18
- 229920009441 perflouroethylene propylene Polymers 0.000 description 18
- 238000005259 measurement Methods 0.000 description 17
- 239000011248 coating agent Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 238000011049 filling Methods 0.000 description 10
- 230000035699 permeability Effects 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000001878 scanning electron micrograph Methods 0.000 description 9
- 230000000712 assembly Effects 0.000 description 8
- 238000000429 assembly Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 238000009877 rendering Methods 0.000 description 8
- 238000010998 test method Methods 0.000 description 7
- 229920001169 thermoplastic Polymers 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000004891 communication Methods 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 230000032798 delamination Effects 0.000 description 6
- 239000004416 thermosoftening plastic Substances 0.000 description 6
- 229920002799 BoPET Polymers 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000013536 elastomeric material Substances 0.000 description 5
- 239000001307 helium Substances 0.000 description 5
- 229910052734 helium Inorganic materials 0.000 description 5
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000003466 anti-cipated effect Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 229920001903 high density polyethylene Polymers 0.000 description 4
- 239000004700 high-density polyethylene Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 229910000619 316 stainless steel Inorganic materials 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229920000249 biocompatible polymer Polymers 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000004626 scanning electron microscopy Methods 0.000 description 3
- 239000004447 silicone coating Substances 0.000 description 3
- 238000005476 soldering Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 238000009864 tensile test Methods 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000005441 aurora Substances 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000003490 calendering Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000013510 multi-purpose sealant Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000004687 Nylon copolymer Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000002156 adsorbate Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- FHTQCUNSKSWOHF-UHFFFAOYSA-N ethyl carbamate;silicon Chemical compound [Si].CCOC(N)=O FHTQCUNSKSWOHF-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000006082 mold release agent Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 238000013001 point bending Methods 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2415—Manufacturing methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
- A61F2/2433—Deployment by mechanical expansion using balloon catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019200491A AU2019200491A1 (en) | 2015-02-13 | 2019-01-24 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
| AU2020250227A AU2020250227A1 (en) | 2015-02-13 | 2020-10-07 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/622,599 US9801712B2 (en) | 2011-04-01 | 2015-02-13 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
| US14/622,599 | 2015-02-13 | ||
| PCT/US2015/042530 WO2016130173A1 (en) | 2015-02-13 | 2015-07-28 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019200491A Division AU2019200491A1 (en) | 2015-02-13 | 2019-01-24 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2015382370A1 true AU2015382370A1 (en) | 2017-08-17 |
Family
ID=54011881
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015382370A Abandoned AU2015382370A1 (en) | 2015-02-13 | 2015-07-28 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
| AU2019200491A Abandoned AU2019200491A1 (en) | 2015-02-13 | 2019-01-24 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
| AU2020250227A Abandoned AU2020250227A1 (en) | 2015-02-13 | 2020-10-07 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019200491A Abandoned AU2019200491A1 (en) | 2015-02-13 | 2019-01-24 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
| AU2020250227A Abandoned AU2020250227A1 (en) | 2015-02-13 | 2020-10-07 | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3256178B1 (enExample) |
| JP (1) | JP6813494B2 (enExample) |
| CN (1) | CN107206122B (enExample) |
| AU (3) | AU2015382370A1 (enExample) |
| BR (1) | BR112017016552A2 (enExample) |
| CA (1) | CA2973346C (enExample) |
| CR (1) | CR20170386A (enExample) |
| ES (1) | ES2860899T3 (enExample) |
| HK (1) | HK1246698A1 (enExample) |
| WO (1) | WO2016130173A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
| US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
| US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
| US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
| EP3389557B1 (en) | 2015-12-15 | 2022-07-13 | Neovasc Tiara Inc. | Transseptal delivery system |
| CN113633435B (zh) | 2016-01-29 | 2024-11-29 | 内奥瓦斯克迪亚拉公司 | 用于防止流出阻塞的假体瓣膜 |
| CN113893064A (zh) | 2016-11-21 | 2022-01-07 | 内奥瓦斯克迪亚拉公司 | 用于快速收回经导管心脏瓣膜递送系统的方法和系统 |
| WO2019036810A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | TRANSCATHETER MITRAL VALVULE PROSTHESIS WITH SEQUENTIAL DEPLOYMENT |
| EP3703768A1 (en) * | 2017-10-31 | 2020-09-09 | W. L. Gore & Associates, Inc. | Synthetic prosthetic valve leaflet |
| CN113271890B (zh) | 2018-11-08 | 2024-08-30 | 内奥瓦斯克迪亚拉公司 | 经导管二尖瓣假体的心室展开 |
| WO2020134920A1 (zh) * | 2018-12-28 | 2020-07-02 | 深圳市先健畅通医疗有限公司 | 覆膜支架及其制备方法 |
| US11998447B2 (en) | 2019-03-08 | 2024-06-04 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
| JP7438236B2 (ja) | 2019-04-01 | 2024-02-26 | ニオバスク ティアラ インコーポレイテッド | 制御可能に展開可能な補綴弁 |
| CN113924065A (zh) | 2019-04-10 | 2022-01-11 | 内奥瓦斯克迪亚拉公司 | 具有自然血流的假体瓣膜 |
| CA3140925A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
| US11311376B2 (en) | 2019-06-20 | 2022-04-26 | Neovase Tiara Inc. | Low profile prosthetic mitral valve |
| JP7711065B2 (ja) * | 2019-12-20 | 2025-07-22 | ゼルティス アーゲー | 多層エレクトロスパン心臓弁尖 |
| US11766326B2 (en) * | 2020-02-18 | 2023-09-26 | Lsi Solutions, Inc. | Method of folding a cardiac repair structure |
| BR112023025577A2 (pt) * | 2021-06-07 | 2024-02-20 | Edwards Lifesciences Corp | Folhetos e separadores de folhetos para válvulas protéticas |
| CN113878955B (zh) * | 2021-09-27 | 2024-02-23 | 宁波健世科技股份有限公司 | 一种多层复合的仿生高分子瓣叶及其制造方法 |
| CN114259607B (zh) * | 2021-12-28 | 2023-01-24 | 宇航 | 一种支架制备方法 |
| CN114259609B (zh) * | 2021-12-28 | 2023-02-28 | 埃恩普裕(北京)科技有限公司 | 一种支架 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA962021A (en) | 1970-05-21 | 1975-02-04 | Robert W. Gore | Porous products and process therefor |
| DE69428056T2 (de) | 1994-09-02 | 2002-01-03 | W.L. Gore & Associates, Inc. | Poröse polytetrafluorethylen zusammensetzungen |
| US7049380B1 (en) | 1999-01-19 | 2006-05-23 | Gore Enterprise Holdings, Inc. | Thermoplastic copolymer of tetrafluoroethylene and perfluoromethyl vinyl ether and medical devices employing the copolymer |
| US6541589B1 (en) | 2001-10-15 | 2003-04-01 | Gore Enterprise Holdings, Inc. | Tetrafluoroethylene copolymer |
| US20040024448A1 (en) | 2002-08-05 | 2004-02-05 | Chang James W. | Thermoplastic fluoropolymer-coated medical devices |
| US7531611B2 (en) | 2005-07-05 | 2009-05-12 | Gore Enterprise Holdings, Inc. | Copolymers of tetrafluoroethylene |
| US7306729B2 (en) | 2005-07-18 | 2007-12-11 | Gore Enterprise Holdings, Inc. | Porous PTFE materials and articles produced therefrom |
| US20070118210A1 (en) * | 2005-11-18 | 2007-05-24 | Leonard Pinchuk | Trileaflet Heart Valve |
| US20080220054A1 (en) * | 2006-10-13 | 2008-09-11 | Shastri V Prasad | Modulation of drug release rate from electrospun fibers |
| US8961599B2 (en) * | 2011-04-01 | 2015-02-24 | W. L. Gore & Associates, Inc. | Durable high strength polymer composite suitable for implant and articles produced therefrom |
| US8945212B2 (en) * | 2011-04-01 | 2015-02-03 | W. L. Gore & Associates, Inc. | Durable multi-layer high strength polymer composite suitable for implant and articles produced therefrom |
| US9737398B2 (en) * | 2012-12-19 | 2017-08-22 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
| EP3459498B1 (en) * | 2013-03-13 | 2020-04-01 | W. L. Gore & Associates Inc | Prosthetic heart valve comprising durable high strength polymer composites suitable for implant |
-
2015
- 2015-07-28 CR CR20170386A patent/CR20170386A/es unknown
- 2015-07-28 ES ES15756503T patent/ES2860899T3/es active Active
- 2015-07-28 EP EP15756503.7A patent/EP3256178B1/en not_active Not-in-force
- 2015-07-28 BR BR112017016552A patent/BR112017016552A2/pt not_active Application Discontinuation
- 2015-07-28 HK HK18105989.2A patent/HK1246698A1/zh unknown
- 2015-07-28 WO PCT/US2015/042530 patent/WO2016130173A1/en not_active Ceased
- 2015-07-28 AU AU2015382370A patent/AU2015382370A1/en not_active Abandoned
- 2015-07-28 CA CA2973346A patent/CA2973346C/en not_active Expired - Fee Related
- 2015-07-28 CN CN201580075853.4A patent/CN107206122B/zh not_active Expired - Fee Related
- 2015-07-28 JP JP2017542435A patent/JP6813494B2/ja not_active Expired - Fee Related
-
2019
- 2019-01-24 AU AU2019200491A patent/AU2019200491A1/en not_active Abandoned
-
2020
- 2020-10-07 AU AU2020250227A patent/AU2020250227A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3256178B1 (en) | 2021-01-13 |
| CA2973346A1 (en) | 2016-08-18 |
| ES2860899T3 (es) | 2021-10-05 |
| HK1246698A1 (zh) | 2018-09-14 |
| CN107206122B (zh) | 2020-11-03 |
| JP6813494B2 (ja) | 2021-01-13 |
| AU2020250227A1 (en) | 2020-11-05 |
| CR20170386A (es) | 2017-10-19 |
| EP3256178A1 (en) | 2017-12-20 |
| AU2019200491A1 (en) | 2019-02-14 |
| WO2016130173A1 (en) | 2016-08-18 |
| CA2973346C (en) | 2021-07-20 |
| JP2018507039A (ja) | 2018-03-15 |
| BR112017016552A2 (pt) | 2018-04-10 |
| CN107206122A (zh) | 2017-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10548724B2 (en) | Coherent single layer high strength synthetic polymer composites for prosthetic valves | |
| CA2973346C (en) | Coherent single layer high strength synthetic polymer composites for prosthetic valves | |
| AU2018201999B2 (en) | Durable high strength polymer composites suitable for implant and articles produced therefrom | |
| US10470878B2 (en) | Durable high strength polymer composites suitable for implant and articles produced therefrom | |
| CA2830355C (en) | Durable high strength polymer composite suitable for implant and articles produced therefrom | |
| AU2020204354A1 (en) | Durable high strength polymer composite suitable for implant and articles produced therefrom | |
| HK40004911B (en) | Prosthetic heart valve comprising durable high strength polymer composites suitable for implant | |
| HK40004911A (en) | Prosthetic heart valve comprising durable high strength polymer composites suitable for implant | |
| HK1216087B (en) | Durable high strength polymer composites suitable for implant and articles produced therefrom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |